This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Echo Therapeutics Inc (ECTE)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 8.06M 3.75M 9.00M 1.34M
Receivables 0.00 0.00 43.73K 426.49K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 968.00K 0.00 0.00 0.00
Total Current Assets 9.38M 5.20M 9.56M 1.96M
Property, Plant & Equipment, Gross 2.74M 2.80M 1.45M 1.22M
Accumulated Depreciation & Depletion 1.25M 1.17M 1.14M 1.17M
Property, Plant & Equipment, Net 1.50M 1.64M 317.73K 48.03K
Intangibles 9.62M 9.62M 9.62M 9.62M
Other Non-Current Assets 2.59M 3.56M 20.56K 275.50K
Total Non-Current Assets 13.71M 14.82M 9.96M 9.95M
Liabilities & Shareholder Equity
Total Assets 23.09M 20.02M 19.53M 11.91M
Accounts Payable 1.04M 2.32M 365.30K 605.63K
Short Term Debt 1.36K 2.53K 2.29K 102.07K
Other Current Liabilities 1.12M 5.59M 1.04M 1.54M
Total Current Liabilities 3.64M 9.58M 2.49M 3.12M
Long Term Debt 0.00 120.83K 3.89K 6.18K
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 76.43K 91.59K 61.87K 82.18K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 76.43K 212.42K 65.76K 88.36K
Total Liabilities 3.72M 9.79M 2.56M 3.21M
Preferred Stock Equity 10.01K 30.16K 30.16K 51.00
Common Stock Equity 19.36M 10.20M 16.94M 8.70M
Common Par 135.25K 443.74K 385.44K 311.26K
Additional Paid In Capital 132.19M 103.66M 98.12M 79.65M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -112.97M -93.90M -81.57M -71.54M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 0.00 0.00 6.67K 285.00K
Total Capitalization 19.37M 10.35M 16.97M 8.71M
Total Equity 19.37M 10.23M 16.97M 8.70M
Total Liabilities & Stock Equity 23.09M 20.02M 19.53M 11.91M
Total Common Shares Outstanding 11.78M 4.44M 3.85M 3.11M
Preferred Shares 2.75M 3.02M 3.02M 5.07K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 8.36M 3.96M 3.42M 2.90M
Diluted Weighted Shares Outstanding 8.36M 3.96M 3.42M 2.90M
Number of Employees 29 44 29 11
Number of Part-Time Employees 0 0 0 0
ECTE News

ECTE Echo Therapeutics Inc

Analysts Ratings for ECTE

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ECTE ANALYST REPORT

Brokerage Partners

ECTE Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs